Counterfoil: medicines sold in India
India's medicines: NPPA prices and ceilings, cheaper same-composition brands, CDSCO failed batches.
사용해야 할까요
품질 및 안전성
발견 사항 (1)
- LOWget_brand에서
도구 정의와 프로토콜 준수에 대한 자동 분석을 기반으로 합니다.
컨텍스트 비용
이는 서버의 도구가 모델의 컨텍스트에 로드될 때마다 소비되는 대략적인 토큰 수입니다. 수치가 높을수록 다른 작업에 사용할 수 있는 주의가 줄어듭니다.
설치
원클릭 설치
`claude_desktop_config.json` 파일에 다음을 추가하세요:
{
"mcpServers": {
"medicines": {
"url": "https://counterfoil.in/mcp"
}
}
}원격 엔드포인트
https://counterfoil.in/mcpstreamable-http할 수 있는 일
도구 목록
도구 (6)
🟢search_medicines(query, limit)
Find Indian medicine brands, compositions (molecules) and companies by name in NPPA's price filings. Start here when you have a brand or generic name. Returns names, pack counts and counterfoil.in pages to cite.
입력 스키마
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "brand, generic name or company; three letters or more"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 10,
"default": 10
}
},
"required": [
"query"
],
"additionalProperties": false
}🟢get_brand(brand)
One Indian medicine brand: every pack with its MRP and price per unit as filed with NPPA, composition, whether it is price-controlled and its ceiling, and the cheapest other brands with the same composition and strength.
입력 스키마
{
"type": "object",
"properties": {
"brand": {
"type": "string",
"description": "brand name (e.g. 'Crocin Advance'), or its counterfoil.in page URL"
}
},
"required": [
"brand"
],
"additionalProperties": false
}🟢compare_prices(molecule, strength, limit)
Every brand of one composition sold in India, lowest price per unit first, with the lowest, median and highest per-unit price for each strength and form. Use for 'cheapest <generic>' or 'how much should <generic> cost'.
입력 스키마
{
"type": "object",
"properties": {
"molecule": {
"type": "string",
"description": "generic name or combination, e.g. 'telmisartan' or 'amoxycillin + clavulanic acid'"
},
"strength": {
"type": "string",
"description": "optional, e.g. '40 MG' or '500/125'"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 25,
"default": 10
}
},
"required": [
"molecule"
],
"additionalProperties": false
}🟢company_profile(company)
An Indian pharmaceutical company group in NPPA's filings: the names it files under, counts of packs, brands and molecules, its largest molecules, batches CDSCO declared not of standard quality, and packs filed above the price ceiling.
입력 스키마
{
"type": "object",
"properties": {
"company": {
"type": "string",
"description": "company name, e.g. 'Cipla', or its counterfoil.in page URL"
}
},
"required": [
"company"
],
"additionalProperties": false
}🟢failed_batches(query, month)
Drug batches that Indian government laboratories declared not of standard quality (CDSCO monthly alerts): product, batch, manufacturer, what it failed on, and the laboratory. Search by product or manufacturer, and/or a month.
입력 스키마
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "product or manufacturer, e.g. 'paracetamol' or 'Hind Pharma'"
},
"month": {
"type": "string",
"description": "optional alert month, YYYY-MM"
}
},
"additionalProperties": false
}🟢above_ceiling(query)
Price-controlled packs whose filed MRP per unit is above NPPA's own ceiling price plus GST, by brand, company or molecule, most above first, with the ceiling order cited.
입력 스키마
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "brand, company or molecule"
}
},
"required": [
"query"
],
"additionalProperties": false
}커뮤니티
증거